WO2015037720A1 - Promoteur de la réparation musculaire - Google Patents

Promoteur de la réparation musculaire Download PDF

Info

Publication number
WO2015037720A1
WO2015037720A1 PCT/JP2014/074291 JP2014074291W WO2015037720A1 WO 2015037720 A1 WO2015037720 A1 WO 2015037720A1 JP 2014074291 W JP2014074291 W JP 2014074291W WO 2015037720 A1 WO2015037720 A1 WO 2015037720A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
milk
muscle synthesis
casein
whey
Prior art date
Application number
PCT/JP2014/074291
Other languages
English (en)
Japanese (ja)
Inventor
淳 神田
恭佑 中山
三本木　千秋
Original Assignee
株式会社明治
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社明治 filed Critical 株式会社明治
Priority to SG11201601774VA priority Critical patent/SG11201601774VA/en
Priority to JP2015536652A priority patent/JPWO2015037720A1/ja
Priority to CN201480050083.3A priority patent/CN105658231A/zh
Publication of WO2015037720A1 publication Critical patent/WO2015037720A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
    • A23C9/1512—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins containing isolated milk or whey proteins, caseinates or cheese; Enrichment of milk products with milk proteins in isolated or concentrated form, e.g. ultrafiltration retentate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum

Definitions

  • the present invention relates to muscle synthesis promoters for subjects in need of immediate protein absorption.
  • Whey protein has a high rate (absorption time) from ingestion to digestion and absorption (short time) and contains a lot of BCAA (branched chain amino acids: valine, leucine, isoleucine), thus preventing muscle fatigue, It is said that muscles can be strengthened efficiently.
  • BCAA branched chain amino acids: valine, leucine, isoleucine
  • casein protein is slowly and continuously metabolized compared to whey protein, so the rate from oral ingestion to digestion absorption (absorption rate) is slow (longer time) and needs immediate absorption. Is said to be unsuitable (see Patent Document 1). Therefore, whey protein is mainly used as protein powder.
  • a mixed protein in which whey protein having high absorption and casein protein to be continuously absorbed are mixed at 1: 1 has been developed (for example, DNS protein slow loading). ).
  • whey protein has low heat resistance (thermal stability), it undergoes thermal denaturation and tends to aggregate due to heating.
  • protein powders are not recommended for consumption other than being dissolved in water. Therefore, protein powder remains powdery and cannot be said to have high palatability.
  • the whey protein is hardened by heat denaturation and there is a problem that the absorption efficiency is lowered.
  • an object of the present invention is to provide a muscle synthesis (enhancement) promoter having an immediate effect of promoting muscle synthesis equivalent to that of whey protein.
  • a muscle synthesis promoter for a subject in need of immediate protein absorption comprising a milk protein mixture containing casein protein and whey protein as an active ingredient, and the amount of casein protein relative to whey protein
  • a muscle synthesis promoter having a ratio (casein protein / whey protein) of 2 to 20.
  • the muscle synthesis promoter described in 1. (4) The muscle synthesis promoter according to any one of (1) to (3) above, wherein the subject in need of immediate protein absorption is a subject to exercise. (5) The muscle synthesis promoter according to (4) above, wherein the exercise is muscle training. (6) The muscle synthesis promoter according to any one of (1) to (5), which is in a liquid form.
  • a packaged container-packed milk drink that is provided with an action for promoting muscle synthesis by immediate protein absorption.
  • a method for producing a packaged-packed milk beverage comprising a step of adding to one or more selected from the group consisting of milk and a step of heat sterilization, wherein the milk protein mixture is 8 g /
  • a milk protein mixture containing casein protein and whey protein having a protein amount ratio of casein protein to whey protein (casein protein / whey protein) of 2 to 20 is taken by a subject who needs immediate absorption of the protein
  • a method of promoting muscle synthesis comprising: (11) A milk protein mixture containing casein protein and whey protein having a protein amount ratio of casein protein to whey protein (casein protein / whey protein) of 2 to 20 is taken by a subject who needs immediate absorption of the protein.
  • a method for promoting muscle synthesis comprising: (12) The method for promoting muscle synthesis according to (10) or (11) above, wherein the milk protein mixture is ingested so that the total protein amount is 0.13 to 0.7 g / kg body weight per serving. (13) The method for promoting muscle synthesis according to (12), wherein the milk protein mixture is ingested so that the total protein amount of the milk protein mixture is 8 to 40 g per serving. (14) The method for promoting muscle synthesis according to any one of the above (10) to (13), comprising ingesting the milk protein mixture in a heated liquid form to a subject in need of immediate absorption of the protein.
  • the muscle synthesis promoter of the present invention has an immediate effect of promoting muscle synthesis equivalent to that of whey protein, and has higher heat resistance and better processability than using whey protein alone. Therefore, the muscle synthesis promoter of the present invention is advantageous in that it can be expected to have an immediate effect of promoting muscle synthesis and can be provided as an inexpensive product form that can be mass-produced commercially.
  • FIG. 1 shows the skeletal muscle synthesis rate (FSR) in the triceps surae muscle and the hyfuku muscle when orally ingesting (administering) milk protein solutions of various concentrations.
  • FIG. 2 shows changes in FSR with swimming exercise.
  • FIG. 3 shows the blood 3MeHis concentration when each concentration of milk protein solution was orally ingested (administered).
  • the muscle synthesis promoter of the present invention is a muscle synthesis promoter for a subject in need of immediate protein absorption, comprising a milk protein mixture containing casein protein and whey protein as an active ingredient. It is a muscle synthesis promoter having a protein amount ratio (casein protein / whey protein) of 2 to 20 to the casein protein.
  • the active ingredient means an ingredient required for exerting an effect of promoting muscle synthesis for a subject requiring immediate absorption of protein.
  • Subjects requiring immediate absorption of protein means subjects who need to promote muscle protein synthesis in order to repair muscle tissue and promote muscle growth, such as health promotion and exercise capacity
  • the exercise is preferably strength training (resistance exercise), more preferably long-term strength training, for example, continuous, in that muscle synthesis is promoted by applying a certain load to the strength.
  • the strength training is continued for 30 minutes to 5 hours at a frequency of 1 to 7 days in a week.
  • Examples of strength training include dumbbell exercise, squat exercise, and machine training.
  • Examples of subjects who take the muscle synthesis promoter of the present invention include, for example, athletes, sports enthusiasts (athletes), those who need exercise to improve lifestyle-related diseases, and elderly people for health promotion. Examples include those who require exercise, or patients who suffer from a muscle injury disease (eg, sarcopenia) and who need to promote muscle synthesis through exercise. Further, the target may be an animal other than a human (domestic animals such as horses and cows, pets such as dogs and cats, appreciation animals kept in zoos, etc.).
  • the time when the muscle synthesis promoter of the present invention is ingested (administered) to a subject in need of immediate protein absorption may be before exercise, after exercise, or during exercise.
  • the time of intake is preferably after exercise, more preferably immediately after exercise.
  • the intake period is preferably within 3 hours after the end of exercise, immediately after exercise. More preferably, within 2 hours after the end of exercise, more preferably within 1 hour after the end of exercise, and particularly preferably within 30 minutes after the end of exercise (Levenhagenhaet al. Am J physiol Endocrinol Metab (2001), 280, E982-E993).
  • Immediately effective muscle synthesis promoting effect equivalent to whey protein is the same level of protein absorption rate and absorption as observed when orally ingesting (administering) a protein mainly composed of whey protein. It means the same level of action as the accompanying muscle synthesis promoting action.
  • the muscle synthesis promoting action includes an anabolic action of muscle protein from amino acids.
  • the muscle synthesis promoting action can be confirmed, for example, by measuring the triceps surae muscle synthesis rate (FSR) of the upper limb in the test group within 1 hour after administration of the test substance after the rat swimming test. it can.
  • FSR triceps surae muscle synthesis rate
  • the muscle synthesis promoting action includes a muscle protein degradation inhibiting action, that is, a catabolic preventing action from muscle protein to amino acid.
  • the degradation inhibitory action of muscle protein can be confirmed by measuring the concentration of 3 methylhistidine within 1 hour after administration of the test substance after, for example, a rat swimming test (Example 1). (See (3)).
  • Protein amount means the amount of protein as a polymer of amino acids contained in various proteins such as milk protein, whey protein or casein protein.
  • Protein amount ratio means the ratio of the amount of protein as a polymer of amino acids contained in various proteins such as milk protein, whey protein, or casein protein.
  • the amount of protein may be calculated based on known information such as a food composition table, or may be calculated by measuring by a conventional method such as Kjeldahl method or Raleigh method. Actually, in the case of the Kjeldahl method, it can be calculated by measuring nitrogen contained in various proteins and multiplying the value by a nitrogen-protein conversion factor (usually 6.25).
  • the milk protein mixture used in the present invention is not particularly limited as long as it contains whey protein and casein protein in a specific protein amount ratio, but the whey protein and casein protein separated and purified separately are not specifically limited. It may be prepared by mixing so as to obtain a protein amount ratio, or a raw material (material) or food and drink that already contains whey protein and casein protein that have not been separated or purified separately in a specific protein amount ratio You may mix and prepare goods. At this time, the milk protein mixture used in the present invention does not require a separation step or purification step of whey protein or casein protein, and the production cost thereof is low, so that whey protein and casein protein are already specified. Prepared by mixing the raw materials and foods and drinks that are contained in the protein content ratio as the main components, and mixing the whey protein and casein protein purified separately as needed to achieve a specific protein content ratio. Is preferred.
  • whey protein separated and purified separately from casein protein examples include whey stock solutions (sweet whey, acid whey, etc.), concentrates, dried products (whey powder, etc.), frozen products, hydrolyzed products, etc. And reducing solutions thereof. Further, desalted whey, whey protein concentrate (WPC), purified whey protein (WPI), ⁇ -lactalbumin ( ⁇ -La), ⁇ -lactoglobulin ( ⁇ -Lg), immunoglobulin, lactoferrin, and the like, and These reducing solutions can be used.
  • Casein protein separated and purified separately from whey protein includes, for example, casein isolate (natural cheese such as fresh cheese, sodium caseinate, calcium caseinate), its concentrate, its dried product, its A frozen material, a hydrolyzate thereof, a reducing solution thereof, and the like can be used. Furthermore, purified products such as ⁇ -casein, ⁇ -casein, and ⁇ -casein, and reducing solutions thereof can be used.
  • raw materials and foods and beverages that already contain whey protein and casein protein in a specific protein ratio include, for example, raw milk, pasteurized milk (such as milk), skim milk, component-adjusted milk, processed milk, and dairy products ( Concentrated milk, powdered milk, condensed milk, fermented milk (yogurt, etc.), lactic acid bacteria beverages, processed cheeses, ice creams, creams), milk protein concentrate (MPC), its concentrate, its dried product, its frozen product, its Hydrolysates and the like, and reducing solutions thereof can be used.
  • MPC milk protein concentrate
  • the milk protein mixture used in the present invention is composed of whey protein and casein protein having a specific protein amount ratio.
  • the protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2 to 20, preferably 2 to 10, more preferably 2 to 6, still more preferably 2 to 4, and particularly preferably 2 to 3.5.
  • the protein ratio (casein protein / whey protein) between casein protein and whey protein is intentionally adjusted (designed), which is greatly different from the conventional technology. Yes.
  • the muscle synthesis promoter of the present invention has high heat resistance (thermal stability) and exhibits a heat resistance effect.
  • having a heat-resistant effect means that the protein does not solidify (aggregate) due to heat denaturation even when it is treated at a specific temperature. Specifically, it is a condition used in general processing of milk. This means that the protein is not heat denatured even if heat-sterilized by the method.
  • the muscle synthesis promoter of the present invention has a heat resistance effect. More specifically, it is heat sterilized (LTLT treatment: low temperature and long time heating) at 62 to 65 ° C.
  • the heat sterilization method includes a batch type in which the processing liquid is heated and held using a tank or the like, an indirect heating type using a plate type heat exchanger or a tube type heat exchanger, and a steam injection type heating device. And a known method such as a direct heating method using a steam infusion type heating device or a current heating method using a Joule heating device can be used.
  • the milk protein mixture is ingested (administered) so that the total protein amount is 0.13 g / kg body weight or more per meal, Specifically, the weight is 0.13 to 0.7 g / kg body weight, preferably 0.13 to 0.6 g / kg body weight, more preferably 0.13 to 0.5 g / kg body weight, still more preferably 0.00. It is ingested (administered) so as to be 15 to 0.4 g / kg body weight, particularly preferably 0.2 to 0.4 g / kg body weight.
  • the typical weight of the subject is estimated to be about 60 kg.
  • one meal means one time in a state requiring immediate absorption of protein.
  • a single meal is not taken at a time (at a time), but several times. May be taken separately.
  • the amino acid concentration in the bloodstream can be increased immediately when it is ingested in several degrees. In this respect, it is preferably within 2 hours after the end of exercise, more preferably within 1 hour after the end of exercise, more preferably within 30 minutes after the end of exercise, and particularly preferably the end of exercise. Within 5 minutes later.
  • the method for ingesting (administering) the muscle synthesis promoter of the present invention to a subject in need of immediate protein absorption can be appropriately selected from oral ingestion (oral administration), enteral administration, gastric fistula and the like depending on the subject and application. Although it can be selected, it is preferably taken orally.
  • the muscle synthesis promoter of the present invention can take any form as long as the effect is exerted, and examples thereof include a solid form, a liquid form, a gel form, a paste form, and a paste form.
  • a solid form among solids, it may be powder, granule, capsule, block, In view of good processability, it is preferably a liquid.
  • a long-term storage period can be set in a refrigerated state and at room temperature.
  • the water content can be appropriately adjusted. Specifically, it may be 10 to 95% by mass, preferably 20 to 95% by mass, and more preferably. Is 30 to 90% by mass, more preferably 40 to 90% by mass.
  • the water content or solid content
  • muscle synthesis can be effectively promoted.
  • the muscle synthesis promoter of the present invention comprises a unit package form per serving, and the milk protein mixture is added to the total amount of food intake in the unit package form. It is desirable that the amount of protein is adjusted to 8 g or more, specifically, 8 to 40 g, preferably 8 to 20 g, more preferably 9 to 20 g, still more preferably 9 to 15 g, particularly preferably 10 to 15 g. It adjusts so that it may become.
  • ⁇ consisting of a unit packaging form per meal '' is a form in which the intake amount per meal is determined in advance, for example, as a food and drink that can be taken orally in a specific amount, not only general foods, It means forms such as beverages (drinks, etc.), health supplements, health functional foods, and supplements.
  • unit packaging form per meal for example, in the case of liquid beverages, gel-like, paste-like, paste-like jelly, powder-like, granule-like, capsule-like, block-like solid foods, etc.
  • a specific amount (dose) can be defined in packaging containers such as cans, glass bottles (such as bottles), plastic containers (such as plastic bottles), packs, pouches, film containers, paper boxes, etc., or intake per serving (usage, dose) ) Is displayed on a packaging container, a homepage, etc., and the form which can prescribe
  • packaging containers such as cans, glass bottles (such as bottles), plastic containers (such as plastic bottles), packs, pouches, film containers, paper boxes, etc., or intake per serving (usage, dose) ) Is displayed on a packaging container, a homepage, etc., and the form which can prescribe
  • the form of the muscle synthesis promoter of the present invention is a so-called health drink
  • 8 to 40 g of the beverage in which the milk protein is suspended or dissolved is provided.
  • the capacity (dose) of a single drink per meal is adjusted by the amount of water so that it is 100 to 1000 ml, and is placed in a packaging container such as a metal can, a glass bottle (such as a bottle), or a plastic container (such as a plastic bottle). (Filled) form.
  • 8 to 40 g of the above-described milk protein suspension or dissolved beverage is displayed on a packaging container or homepage as the amount of intake (usage, dose) (for example, 100 to 1000 ml) per serving, and several servings (several (Batch) is a collective capacity, and is a form that is put (filled) in a large-capacity packaging container or the like.
  • the muscle synthesis promoter of the present invention is manufactured so as to contain a predetermined milk protein mixture
  • its manufacturing process is not limited.
  • the muscle synthesis promoter of the present invention includes various components such as milk protein and milk fat with respect to raw milk (raw milk), sterilized milk, concentrated milk, powdered milk, and reduced milk according to a known manufacturing method (manufacturing method). It can be manufactured by blending (adjusting) the ingredients, or various ingredients such as milk protein and milk fat can be blended (adjusted) with component-adjusted milk and processed milk (such as low-fat milk and non-fat milk). ) Can also be manufactured.
  • the muscle synthesis promoter of the present invention can provide a composition comprising a muscle synthesis promoter. That is, the muscle synthesis promoter of the present invention can be used alone as it is, but as long as the muscle synthesis promotion function is exhibited, various compositions for oral intake (for oral administration) such as foods and drinks and pharmaceuticals. A composition (for example, a pharmaceutical composition or a food / beverage product composition) having an immediate effect of promoting muscle synthesis can also be obtained. Therefore, according to one embodiment of the present invention, a composition comprising the muscle synthesis promoter of the present invention is provided.
  • Food and drink is something other than a pharmaceutical product (pharmaceutical composition), as long as it can be taken orally, such as a solution, suspension, emulsion, powder, solid molded product, etc.
  • a pharmaceutical product pharmaceutical composition
  • Well not particularly limited.
  • food and drink include instant noodles, retort food, canned food, microwave food, instant soup and miso soup, freeze-dried food, etc .; soft drinks, fruit juice drinks, vegetable drinks, soy milk drinks, coffee Beverages such as beverages, tea beverages, powdered beverages, concentrated beverages, alcoholic beverages; flour products such as bread, pasta, noodles, cake mixes, bread crumbs; strawberries, caramel, chewing gum, chocolate, cookies, biscuits, cakes, pies, snacks , Crackers, Japanese confectionery, dessert confectionery, etc .; sauces, tomato processing seasonings, flavor seasonings, cooking mixes, sauces, dressings, soups, curry and stew ingredients; processed oils and fats, butter Oils and fats such as margarine and mayonnaise; milk drinks, fermented milk (yogurt, etc.), lactic acid bacteria drinks, natural tea 'S, process cheese, ice cream, dairy products such as cream; agricultural canning, jam, marmalade such, processed agricultural products such as serial; such as frozen food, and the like.
  • Foods and drinks include health foods, functional foods, dietary supplements, foods for specified health use, foods for the sick, infant formula, powdered milk for pregnant or lactating women, or rapid muscle synthesis.
  • subjected the indication that it is a thing used for promotion is also included.
  • “Pharmaceuticals” are those prepared as oral preparations or parenteral preparations in accordance with conventional methods, using additives that are acceptable for formulation.
  • the pharmaceutical is an oral preparation, it should be in the form of a solid preparation such as a tablet, powder, fine granule, granule, capsule, pill or sustained release, or a liquid preparation such as a solution, suspension or emulsion. Can take.
  • a pharmaceutical is a parenteral formulation, it can take the form of an injection or a suppository. In terms of ease of ingestion (administration) to a patient, the pharmaceutical is preferably an oral preparation.
  • additives that are acceptable for formulation include, for example, excipients, stabilizers, preservatives, wetting agents, emulsifiers, lubricants, sweeteners, coloring agents, fragrances, buffers, antioxidants. Agents, pH adjusters and the like.
  • the muscle synthesis promoter of the present invention has a heat resistance effect. Therefore, in the composition in which the muscle synthesis promoter of the present invention is blended (added, mixed), the muscle synthesis promoter of the present invention has a heat-resistant effect, so that it can be preferably provided as a liquid product form. It can be provided as a product form for warm sales using a hot vendor or the like.
  • composition of the muscle synthesis promoter of the present invention may be in any form as long as the effect is exerted, for example, solid, liquid, gel, Examples include pasty and pasty forms.
  • the composition containing the muscle synthesis promoter of the present invention may be in the form of a solid, powder, granule, capsule, or block. However, it is preferably a liquid in terms of good processability.
  • the present invention is a food / beverage product obtained by blending (adding, mixing) and heat-sterilizing the muscle synthesis promoter of the present invention, comprising a unit packaging form per serving, and the unit packaging form Among them, it is desirable that the milk protein mixture is adjusted to a total protein amount of 8 to 40 g as a single meal intake, preferably 8 to 20 g, more preferably 9 to 20 g, still more preferably 9 to 15 g, particularly preferably.
  • Food / beverage products and methods for producing the same are provided, which are provided with an effect of promoting muscle synthesis by immediate absorption of protein, adjusted to 10 to 15 g.
  • the operation (process) of “mixing (addition, mixing) and heat sterilization” to a predetermined component is not particularly limited as long as the operation is finally adjusted to a predetermined component and sterilized. Operation that mixes all necessary components and adjusts them to the prescribed components and then heat sterilizes them together, or operation that sterilizes the necessary individual components separately and mixes them to adjust them to the prescribed components Etc. Therefore, in the present invention, the order and number of times of this blending (addition, mixing) and heat sterilization are arbitrary.
  • the food / beverage product (the food / beverage product of the present invention) is preferably a food / beverage product packed in a packaging container, and more preferably a food / beverage product packed in a packaging container for heat sale. That is, since the food and drink have heat resistance, the protein will not be extremely denatured even if it is heated and sold. Therefore, in the food and drink composed only of the conventional whey protein or the whey protein as a main component, as a warm food and drink, it could not be provided outdoors in winter, etc., whereas in the food and drink, as a warm food and drink, It can be provided outdoors in winter (especially in cold conditions) and can be consumed (drinked) by consumers.
  • the practical use of the food-drinks with the effect of accelerating muscle synthesis corresponding to new needs can be expected.
  • a hot sale beverage or a hot sale food stored in a hot vendor or hot water for example, a hot sale beverage or a hot sale food stored in a hot vendor or hot water, and a necessary amount are put in a cooking utensil.
  • heated beverages and heated foods heated by gas stoves, electric heating stoves, microwaves, and the like can be mentioned.
  • warm sales it is generally stored at around 30-80 ° C or around 50-80 ° C.
  • the food or drink is a milk drink.
  • milk beverage means a beverage containing milk solids (a combination of nonfat milk solids and milk fat) at 3.0% by weight or more.
  • vitamins, minerals, oligosaccharides, lactose, fruit juice and the like can be blended in the milk beverage.
  • the production process is not limited as long as the food or drink is produced so as to contain a predetermined milk protein mixture (at a predetermined concentration). It can manufacture based on manufacturing processes, such as adjusted milk, processed milk, and a milk drink.
  • the food / beverage products of this invention mix
  • a packaged container-packed milk beverage that is preferably adjusted to 0.5 to 4 g / 200 ml, particularly preferably 0.5 to 3
  • a milk protein mixture comprising casein protein and whey protein, wherein the protein amount ratio of casein protein to whey protein (casein protein / whey protein) is 2 to 20,
  • a method for producing a packaged-packed milk beverage comprising a step of adding to one or more selected from the group consisting of raw milk, pasteurized milk, concentrated milk, powdered milk and reduced milk, and a heat sterilization step, wherein the milk protein
  • the total protein amount of the mixture is adjusted to 8 g / 200 ml, preferably 8 to 20 g / 200 ml, more preferably 9 to 20 g / 200 ml, still more preferably 9 to 15 g / 200 ml, particularly preferably 10 to 15 g / 200 ml
  • Milk fat content is 8g or less / 200ml, preferably 0.1-8g 200 ml, more preferably 0.1 to 6 g / 200 ml, further preferably 0.5 to 4 g / 200 ml,
  • “Reduced milk” means liquid milk prepared by dispersing and dissolving milk raw materials such as powdered milk and concentrated milk in water.
  • milk raw material include whole milk powder, skim milk powder, whole fat concentrated milk, nonfat concentrated milk, butter, cream, and unfinished milk.
  • aggregation due to heat denaturation of the whey protein is not observed (see Example 2), and therefore, the immediate protein absorption effect is maintained as in the muscle synthesis promoter of the present invention.
  • a milk protein mixture comprising casein protein and whey protein, wherein the protein content ratio of casein protein to whey protein (casein protein / whey protein) is 2 to 20,
  • a method of promoting muscle synthesis comprising ingesting a subject in need of absorption.
  • a milk protein mixture containing casein protein and whey protein having a protein amount ratio of casein protein to whey protein (casein protein / whey protein) of 2 to 20 is instantly absorbed by the protein.
  • a method for promoting muscle synthesis comprising ingesting a subject in need thereof.
  • the “medical action for humans” means an action that requires a doctor or the like to ingest (administer) a medicine to a human.
  • the muscle synthesis promoting method of the present invention can be carried out according to the contents described in the present specification for the muscle synthesis promoting agent of the present invention.
  • the milk protein mixture is ingested (administered) so that the total protein amount is 0.13 g / kg body weight or more per meal.
  • the weight is 0.13-0.7 g / kg body weight, preferably 0.13-0.6 g / kg body weight, more preferably 0.13-0.5 g / kg body weight, still more preferably It can be ingested so as to be 0.15 to 0.4 g / kg body weight, particularly preferably 0.2 to 0.4 g / kg body weight.
  • the milk protein mixture in the method for promoting muscle synthesis of the present invention, can be ingested so that the total protein amount is 8 g or more per serving. It can be ingested so as to be ⁇ 40 g, preferably 8 to 20 g, more preferably 9 to 20 g, still more preferably 9 to 15 g, particularly preferably 10 to 15 g.
  • the milk protein mixture in the muscle synthesis promotion method of the present invention, can be ingested in a heated liquid form to a subject that needs immediate absorption of the protein.
  • a muscle synthesis promoting agent comprising a milk protein mixture comprising casein protein and whey protein for promoting muscle synthesis of a subject in need of immediate protein absorption.
  • a muscle synthesis promoter having a protein amount ratio of casein protein to whey protein (casein protein / whey protein) of 2 to 20 is provided.
  • the use of the muscle synthesis promoter of the present invention can be carried out according to the contents described herein for the muscle synthesis promoter of the present invention.
  • a milk protein mixture comprising casein protein and whey protein for the manufacture of a food or beverage or pharmaceutical product for promoting muscle synthesis in a subject in need of immediate protein absorption.
  • a muscle synthesis promoter comprising a muscle synthesis promoter having a protein content ratio of casein protein to whey protein (casein protein / whey protein) of 2 to 20 is provided.
  • the use of the muscle synthesis promoter of the present invention can be carried out according to the contents described herein for the muscle synthesis promoter of the present invention.
  • muscle synthesis promoting effect muscle synthesis promoting effect
  • body water retention action body water retention effect
  • Example 1 Muscle synthesis promoting action by milk protein mixture
  • Rat swimming test SD male rats obtained from CLEA Japan, Inc. having an initial weight of 140 to 160 g were used as experimental animals. Rats were divided into 6 groups of 9 to 10 animals so that there was no difference in body weight between test groups (groups). All rats were individually housed in stainless steel cages at room temperature of 22 ⁇ 2 ° C. with a light period of 7 to 19 o'clock and a dark period of 19 to 7 o'clock.
  • rats were preliminarily raised for 3 to 4 days, and the rats were subjected to a swimming test according to the following protocol (the rats were exercised).
  • Rat swimming test (exercise) protocol Day 1: Rats were subjected to 2 hours of swimming exercise, 45 minutes of rest, 2 hours of swimming exercise for a total of 4 hours of swimming without weight load. The diet after exercise (solid feed MF) was freely taken. Day 2: The rats were subjected to 3 hours of swimming exercise, 45 minutes of rest, 3 hours of swimming exercise for a total of 6 hours without weight load. The diet after exercise (solid feed MF) was freely taken. Day 3: Rats were subjected to a total of 6 hours of swimming exercise without weight load, 3 hours of swimming exercise, 45 minutes of rest, 3 hours of swimming exercise. As a diet after exercise, 5 g of a restricted diet (powder feed MF) was ingested.
  • a restricted diet porice feed MF
  • the rats were subjected to a 2-hour swimming exercise without weight load.
  • a milk beverage (milk protein solution) was prepared using milk protein and milliQ water so that the protein concentrations shown in Table 1 were obtained.
  • the rats were orally ingested milk drink and milliQ water at 24.24 ml / kg BW (test group 1-5 and comparative group 1).
  • the milk protein includes milk protein concentrate (MPC480, manufactured by Fontera, milk protein 77.2% by weight, milk fat content 1.2% by weight, lactose 9.2% by weight, ash content 7.1% by weight, Water (5.3 wt%) was used.
  • This MPC480 is a mixture of casein protein and whey protein obtained by subjecting skim milk to membrane separation treatment (UF treatment, MF treatment, etc.), removing lactose and ash, and concentrating mainly on casein protein and whey protein.
  • the form is a dry powder.
  • apparatus LC / MS / MS (manufactured by Waters), column: ACQUITY UPLC BEH C18 (manufactured by Waters), mobile phase: 0.05% TFA water / 0.05% TFA-containing acetonitrile, injection volume 3 ⁇ l, flow rate 0.3 ml / min, UV 215 nm.
  • FSR skeletal muscle synthesis rate
  • the obtained numerical values were statistically processed to obtain an average value ⁇ standard error. Specifically, a one-way analysis of variance was performed, followed by Tukey's multiple comparison test. The significance level was less than 5% (p ⁇ 0.05). The result is shown in FIG. When there was a significant difference in the figure, different characters were attached. For example, it is shown that there is a significant difference between a group with a (comparison group 1 or the like) and a group with b (test group 3) or a group with c (test group 4 or the like). ing. Further, for example, it is shown that there is no significant difference between a group to which a (comparison group 1 or the like) or b (test group 3) is attached and a group to which ab is attached (test group 2).
  • the obtained numerical values were statistically processed to obtain an average value ⁇ standard error. Specifically, a one-way analysis of variance was performed, followed by Tukey's multiple comparison test. The significance level was less than 5%. The result is shown in FIG. When there was a significant difference in the figure, different characters were attached.
  • Example 2 Muscle synthesis promoting action by milk beverage containing milk protein (1) Preparation (production) of milk beverage containing milk protein Raw milk (milk protein 3.3 wt%, milk fat 3.8 wt%, lactose 4.8 wt%, ash 0.7 wt%, moisture 87.4 wt%, obtained from Meiji Co., Ltd.) Protein was added and mixed to prepare raw milk so that the milk protein concentration shown in Table 2 was obtained. And according to the usual method for producing milk, the indirect heating method using a plate heat exchanger is sterilized by heating at 130 ° C. for 2 seconds, and then cooled to 10 ° C. or lower, so that the milk protein has a high concentration. (Milk test solution 6 and 7) was obtained.
  • Raw milk milk protein 3.3 wt%, milk fat 3.8 wt%, lactose 4.8 wt%, ash 0.7 wt%, moisture 87.4 wt%, obtained from Meiji Co., Ltd.
  • the milk protein added to the milk beverage includes milk protein concentrate (MPC480, manufactured by Fontera, milk protein 77.2% by weight, milk fat content 1.2% by weight, lactose 9.2% by weight, ash content 7 0.1 wt%, water 5.3 wt%).
  • MPC480 is a mixture of casein protein and whey protein obtained by subjecting skim milk to membrane separation treatment (UF treatment, MF treatment, etc.), removing lactose and ash, and concentrating mainly on casein protein and whey protein.
  • the form is a dry powder.
  • FSR skeletal muscle synthesis rate
  • test sections 6 and 7 were as high as 6.7% / day and 7.7% / day, respectively.
  • the FSR is 8.8% / day when whey protein is taken orally at 3.11 g / kg BW after 2 hours of treadmill exercise as a protein amount. , J. Nutr. 137, 357-362 (2007)).

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

　L'invention concerne un promoteur de la réparation musculaire destiné à être utilisé dans une cible dont l'absorption rapide des protéines est requise, et contenant comme ingrédient efficace un mélange de lactoprotéines qui inclut de la protéine de caséine et de la protéine de lactosérum, le promoteur de la réparation musculaire ayant un rapport protéique de la protéine de caséine à la protéine de lactosérum (protéine caséine/protéine lactosérum) de 2-20. Le promoteur de la réparation musculaire a une action favorisant la réparation musculaire rapide équivalente à celle de la protéine de lactosérum.
PCT/JP2014/074291 2013-09-12 2014-09-12 Promoteur de la réparation musculaire WO2015037720A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SG11201601774VA SG11201601774VA (en) 2013-09-12 2014-09-12 Muscle synthesis promoter
JP2015536652A JPWO2015037720A1 (ja) 2013-09-12 2014-09-12 筋肉合成促進剤
CN201480050083.3A CN105658231A (zh) 2013-09-12 2014-09-12 肌肉合成促进剂

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013-189703 2013-09-12
JP2013189703 2013-09-12

Publications (1)

Publication Number Publication Date
WO2015037720A1 true WO2015037720A1 (fr) 2015-03-19

Family

ID=52665816

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2014/074291 WO2015037720A1 (fr) 2013-09-12 2014-09-12 Promoteur de la réparation musculaire

Country Status (4)

Country Link
JP (1) JPWO2015037720A1 (fr)
CN (1) CN105658231A (fr)
SG (1) SG11201601774VA (fr)
WO (1) WO2015037720A1 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016121923A1 (fr) * 2015-01-29 2016-08-04 株式会社明治 Promoteur de synthèse musculaire
WO2017026429A1 (fr) * 2015-08-10 2017-02-16 株式会社明治 Agent favorisant la synthèse du muscle
WO2018164251A1 (fr) * 2017-03-10 2018-09-13 株式会社明治 Composition pour améliorer la résistance physique
WO2019124355A1 (fr) * 2017-12-18 2019-06-27 株式会社明治 Lait fermenté activant la synthèse musculaire
WO2020013307A1 (fr) * 2018-07-13 2020-01-16 株式会社明治 Procédé de production d'un yogourt concentré
JP2020014452A (ja) * 2018-07-13 2020-01-30 株式会社明治 濃縮発酵乳の製造方法
WO2020085409A1 (fr) * 2018-10-25 2020-04-30 味の素株式会社 Agent d'amélioration du corps
US20210329949A1 (en) * 2020-04-27 2021-10-28 Leprino Performance Brands LLC Protein-fortified beverages for enhanced athletic performance

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI761487B (zh) * 2017-04-06 2022-04-21 日商明治股份有限公司 用於促進血中胺基酸濃度上升之發酵乳
CN114431380A (zh) * 2022-02-25 2022-05-06 广东君悦营养医学有限公司 一种适用于肌肉衰减综合症的蛋白水及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012110705A1 (fr) * 2011-02-18 2012-08-23 Valio Ltd Produit à base de lait et son procédé de préparation
JP2013517808A (ja) * 2010-01-29 2013-05-20 アボット・ラボラトリーズ カルシウムｈｍｂを含む栄養エマルジョン
JP2013517807A (ja) * 2010-01-29 2013-05-20 アボット・ラボラトリーズ Ｈｍｂを含有するプラスチック包装栄養液剤

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013517808A (ja) * 2010-01-29 2013-05-20 アボット・ラボラトリーズ カルシウムｈｍｂを含む栄養エマルジョン
JP2013517807A (ja) * 2010-01-29 2013-05-20 アボット・ラボラトリーズ Ｈｍｂを含有するプラスチック包装栄養液剤
WO2012110705A1 (fr) * 2011-02-18 2012-08-23 Valio Ltd Produit à base de lait et son procédé de préparation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DAICHI NAKAJIMA ET AL.: "Effect of total milk proteins ingestion on muscle mass and body fat", FOOD STYLE 21, vol. 16, no. 9, 2012, pages 76 - 78 *
TAKAYUKI KITAGISHI ET AL.: "Intake of total milk proteins and prevention of sarcopenia", FOOD STYLE 21, vol. 17, no. 4, 1 April 2013 (2013-04-01), pages 56 - 58 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016121923A1 (fr) * 2015-01-29 2016-08-04 株式会社明治 Promoteur de synthèse musculaire
WO2017026429A1 (fr) * 2015-08-10 2017-02-16 株式会社明治 Agent favorisant la synthèse du muscle
JPWO2017026429A1 (ja) * 2015-08-10 2018-05-31 株式会社明治 筋肉合成促進剤
WO2018164251A1 (fr) * 2017-03-10 2018-09-13 株式会社明治 Composition pour améliorer la résistance physique
WO2019124355A1 (fr) * 2017-12-18 2019-06-27 株式会社明治 Lait fermenté activant la synthèse musculaire
JPWO2019124355A1 (ja) * 2017-12-18 2020-12-10 株式会社明治 筋肉合成促進用発酵乳
WO2020013307A1 (fr) * 2018-07-13 2020-01-16 株式会社明治 Procédé de production d'un yogourt concentré
JP2020014452A (ja) * 2018-07-13 2020-01-30 株式会社明治 濃縮発酵乳の製造方法
WO2020085409A1 (fr) * 2018-10-25 2020-04-30 味の素株式会社 Agent d'amélioration du corps
US20210329949A1 (en) * 2020-04-27 2021-10-28 Leprino Performance Brands LLC Protein-fortified beverages for enhanced athletic performance

Also Published As

Publication number Publication date
CN105658231A (zh) 2016-06-08
JPWO2015037720A1 (ja) 2017-03-02
SG11201601774VA (en) 2016-04-28

Similar Documents

Publication Publication Date Title
WO2015037720A1 (fr) Promoteur de la réparation musculaire
JP6728071B2 (ja) 筋肉合成促進剤
WO2006017374A2 (fr) Composition de supplement nutritionnel et procede correspondant
JP7108521B2 (ja) 体内ｂｄｎｆ量増加促進用組成物
US20050112177A1 (en) Nutritional supplement composition and method
WO2017026429A1 (fr) Agent favorisant la synthèse du muscle
US20060062827A1 (en) Nutritional supplement composition and method
JP6037595B2 (ja) 満腹感誘導組成物及びその製造方法
JP2019031466A (ja) 血糖値上昇の抑制又は改善用組成物
JP6430386B2 (ja) 体水分保持剤
EP3386316B1 (fr) Compositions
WO2016133036A1 (fr) Agent d'amélioration de fatigue
WO2018123873A1 (fr) Composition pour favoriser la transpiration
WO2018164251A1 (fr) Composition pour améliorer la résistance physique
WO2018139624A1 (fr) Composition pour favoriser la sécrétion d'insuline
EP4304366A1 (fr) Compositions nutritionnelles et procédés associés
WO2018074415A1 (fr) Composition pour améliorer le coefficient d'efficacité protéique
JP2019024389A (ja) 筋力向上用アミノ酸組成物

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14844506

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2015536652

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14844506

Country of ref document: EP

Kind code of ref document: A1